Hims & Hers Health Stock
Hims & Hers Health, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Andrew Dudum
- Employees
- 2,442
- Market cap
- $6.3 B
- IPO
- 13/09/2019
- Web
- www.hims.com
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Hims & Hers Health stock: price history
1D
-4.5%
1W
-9.2%
1M
+0.3%
6M
-2.6%
YTD
-13.6%
1Y
-52.5%
2Y
+25.5%
5Y
+235.8%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~55% stronger price swings than usual
Ask the agents about Hims & Hers Health
Analyst assessment of Hims & Hers Health
PRICE TARGET LOW
US$24.50
CONSENSUS
US$32.17
MEDIAN
US$32.00
PRICE TARGET HIGH
US$42.00
0
STRONG BUY
7
BUY
13
HOLD
0
SELL
0
STRONG SELL
20
TOTAL · Hold
As of: 24/08/2026
Hims & Hers Health stock metrics
P/E
-46.02
P/B
20.07
EV/EBITDA
-94.88
RETURN ON EQUITY
-26.6%
NET MARGIN
-11.5%
DEBT/EQUITY
4.77
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.2%
FLOAT SHARES
211,877,790
AVG. DAILY VOLUME (30D)
10,064,963
Insider transactions (SEC)
Boughton Soleil
Boughton Soleil
Okupe Oluyemi
Okupe Oluyemi
Okupe Oluyemi
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -4.5%
Forums (Reddit)
See the full forum history with Pro.
Institutional holders
Comparable stocks
Frequently asked questions about Hims & Hers Health stock
What does Hims & Hers Health do?
Hims & Hers Health, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Andrew Dudum, the company employs around 2,442 people.
The IPO was on 13/09/2019; the stock trades on NYSE under the ticker HIMS.
What do analysts say about Hims & Hers Health stock?
20 analysts rate the stock, the consensus is Hold (as of 24/08/2026).
The average price target is US$32.17, ranging from US$24.50 to US$42.00, with a median of US$32.00.
This is an external assessment, not a statement by Market Jury.
When does Hims & Hers Health report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 55% stronger than usual.
Does Hims & Hers Health pay a dividend?
No, Hims & Hers Health currently does not pay a dividend.
Which stocks are comparable to Hims & Hers Health?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, LifeStance Health Group, Concentra Group Holdings Parent, Acadia Healthcare Company and Aveanna Healthcare Holdings.
How can I get Hims & Hers Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Hims & Hers Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.